Deutsche Bank cuts Brenntag to “hold,” slashes price target by 30.7%

Deutsche Bank downgraded Brenntag AG to "hold" from "buy," sharply reducing its price target to €52 from €75, citing heightened cyclicality and pricing pressure within its Essentials segment. This follows Brenntag's reduced 2025 EBITA guidance to €950M-€1.05B from €1.1B-€1.3B, driven by weakening Q2 pricing and volumes. Deutsche Bank's revised 2025 EBITA forecast of €990M, 7% below consensus, reflects ongoing concerns over the company's cyclical end-market exposure and limited structural growth drivers, contributing to a 2.1% decline in Brenntag shares.

Analysis

Deutsche Bank has downgraded Brenntag AG to "hold" from "buy" and executed a significant 30.7% reduction in its price target to €52, citing heightened cyclicality and persistent pricing pressure in the company's Essentials segment. This analyst action follows Brenntag's own downward revision of its 2025 EBITA guidance to a range of €950 million to €1.05 billion, a notable decrease from the prior €1.1 billion to €1.3 billion. The company's guidance cut is directly linked to a quarter-over-quarter EBITA decline in Q2, which underscores the material impact of weakening pricing and volumes. Reinforcing its cautious stance, Deutsche Bank's 2025 EBITA forecast of €990 million is positioned at the lower end of the new guidance and sits approximately 7% below current market consensus, signaling potential for further estimate revisions. The bank's core concerns center on Brenntag's exposure to cyclical end-markets and an apparent lack of structural growth catalysts, which complicates the outlook for a timely recovery despite the stock's 2.1% decline on the news.

Key Decisions for Investors

• Given the dual negative catalysts of a significant analyst downgrade and a company-led guidance reduction, investors should reassess their holding thesis on Brenntag, particularly concerning its exposure to cyclical pressures and weakening pricing power.
• Potential investors should exercise caution, as the share price decline reflects fundamental deterioration; waiting for signs of stabilization in pricing and volumes within the Essentials segment may be a more prudent entry strategy.
• Monitor upcoming earnings reports for any stabilization in EBITA, pricing, and volumes, and watch for further consensus estimate revisions, as Deutsche Bank's forecast is now 7% below the current street view, indicating a potential downside risk to market expectations.